Point-of-care diagnostics for niche applications

Biotechnology Advances

Volumn 34, Issue 3, 2016, Pages 161-176

  Cummins, Brian M ^a   Ligler, Frances S ^a   Walker, Glenn M ^a  

^a USA and North Carolina State University   (United States)

Author keywords

Diagnostics; Emergency care; Operating room; Point of care; Space travel; Sports medicine; Veterinary

Indexed keywords

ANALYTIC EQUIPMENT; BIOCHEMISTRY; CHEMICAL LABORATORIES; CLINICAL LABORATORIES; CLINICAL RESEARCH; OPERATING ROOMS; PLASMA DIAGNOSTICS; SPORTS; SPORTS MEDICINE; VETERINARY MEDICINE;

COMMERCIAL PRODUCTS; EMERGENCY CARE; EMERGENCY MEDICINE; NICHE APPLICATIONS; POINT OF CARE; POINT OF CARE DIAGNOSTIC; SPACE TRAVEL; VETERINARY;

DIAGNOSIS;

ANALYTICAL METHOD; ANIMAL; ASSAY; BUILDING; EQUIPMENT; HOSPITAL SECTOR; INFORMATION; LITERATURE REVIEW; MEDICINE; PUBLIC HEALTH;

ANIMALIA;

ANIMAL; HOSPITAL EMERGENCY SERVICE; HUMAN; OPERATING ROOM; ORGANIZATION AND MANAGEMENT; POINT OF CARE SYSTEM; SPACE FLIGHT; SPORTS MEDICINE; TRENDS; UTILIZATION; VETERINARY MEDICINE;

ANIMALS; EMERGENCY SERVICE, HOSPITAL; HUMANS; OPERATING ROOMS; POINT-OF-CARE SYSTEMS; SPACE FLIGHT; SPORTS MEDICINE; VETERINARY MEDICINE;

EID: 84969351861     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2016.01.005     Document Type: Review

References (220)

1. Agarwal S., Johnson R.I., Shaw M. Preoperative point-of-care platelet function testing in cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2015, 29:333-341.
2. Ahmad T., Fiuzat M., Felker G.M., O'Connor C. Novel biomarkers in chronic heart failure. Nat. Rev. Cardiol. 2012, 9:347-359.
3. Aldam P., Levy N., Hall G.M. Perioperative management of diabetic patients: new controversies. Br. J. Anaesth. 2014, 113:906-909.
4. Almond C.S.D., Shin A.Y., Fortescue E.B., Mannix R.C., Wypij D., Binstadt B.A., et al. Hyponatremia among runners in the Boston Marathon. N. Engl. J. Med. 2005, 352:1550-1556.
5. Antman E., Bassand J.P., Klein W., Ohman M., Lopez Sendon J.L., Rydén L., et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 2000, 36:959-969.
6. Apori A.A., Herr A.E. Homogeneous immunosubtraction integrated with sample preparation enabled by a microfluidic format. Anal. Chem. 2011, 83:2691-2698.
7. Apple F.S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin. Chem. 2012, 58:54-61.
8. Apple F.S., Christenson R.H., Valdes R., Andriak A.J., Berg A., Duh S.H., et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin. Chem. 1999, 45:199-205.
9. Babington R., Matas S., M-P Marco, R Galve Current bioanalytical methods for detection of penicillins. Anal. Bioanal. Chem. 2012, 403:1549-1566.
10. Babuin L., Jaffe A.S. Troponin: the biomarker of choice for the detection of cardiac injury. Can. Med. Assoc. J. 2005, 173:1191-1202.
11. Bai H., Wang R., Hargis B., Lu H., Li Y. A SPR aptasensor for detection of avian influenza virus H5N1. Sensors 2012, 12:12506-12518.
12. Bardakci H., Altintaş G., Çiçek OF, Kervan U., Yilmaz S., Kaplan S., et al. Comparison of the CoaguChek XS handheld coagulation analyzer and conventional laboratory methods measuring international normalised ratio (INR) values during the time to therapeutic range after mechanical valve surgery. J. Card. Surg. 2013, 28:254-257.
13. Berger D. A brief history of medical diagnosis and the birth of the clinical laboratory. Part 2 - laboratory science and professional certification in the 20th century. MLO Med. Lab. Obs. 1999, 31:32-38.
14. Berger D. A brief history of medical diagnosis and the birth of the clinical laboratory. Part 3 - medicare, government regulation, and competency certification. MLO Med. Lab. Obs. 1999, 31:40-44.
15. Bezegh K., Bezegh A., Black P.G., Janata J. Integrated probe for sweat analysis. J. Clin. Lab. Anal. 1988, 2:16-18.
16. Bieglmayer C., Prager G., Niederle B. Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin. Chem. 2002, 48:1731-1738.
17. Bieglmayer C., Kaczirek K., Prager G., Niederle B. Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin. Chem. 2006, 52:1112-1119.
18. Bingisser R., Cairns C., Christ M., Hausfater P., Lindahl B., Mair J., et al. Cardiac troponin: a critical review of the case for point-of-care testing in the ED. Am. J. Emerg. Med. 2012, 30:1639-1649.
19. Bittl J.A. The truth about activated clotting time measurements. Catheter. Cardiovasc. Interv. 2005, 65:338-339.
20. Blakely W.F., Miller A.C., Grace M.B., McLeland C.B., Luo L., Muderhwa J.M., et al. Radiation biodosimetry: applications for spaceflight. Adv. Space Res. 2003, 31:1487-1493.
21. Brancaccio P., Maffulli N., Buonauro R., Limongelli F.M. Serum enzyme monitoring in sports medicine. Clin. Sports Med. 2008, 27:1-18. (vii).
22. Braunwald E. Biomarkers in heart failure. N. Engl. J. Med. 2008, 358:2148-2159.
23. Bruls D.M., Evers T.H., Kahlman J.A.H., Van Lankvelt P.J.W., Ovsyanko M., Pelssers E.G.M., et al. Rapid integrated biosensor for multiplexed immunoassays based on actuated magnetic nanoparticles. Lab Chip 2009, 9:3504-3510.
24. Buckey J. Preparing for Mars: the physiologic and medical challenges. Eur. J. Med. Res. 1999, 4:353-356.
25. Buckley J.D., Bourdon P.C., Woolford S.M. Effect of measuring blood lactate concentrations using different automated lactate analysers on blood lactate transition thresholds. J. Sci. Med. Sport 2003, 6:408-421.
26. Burke M.D. Laboratory medicine in the 21st century. Am. J. Clin. Pathol. 2000, 114:841-846.
27. Cakmak O., Ermek E., Kilinc N., Bulut S., Baris I., Kavakli I.H., et al. A cartridge based sensor array platform for multiple coagulation measurements from plasma. Lab Chip 2015, 15:113-120.
28. Callender G.G., Udelsman R. Surgery for primary hyperparathyroidism. Cancer 2014, 120:3602-3616.
29. Cao Y., Shi S., Wang L., Yao J., Yao T. Ultrasensitive fluorescence detection of heparin based on quantum dots and a functional ruthenium polypyridyl complex. Biosens. Bioelectron. 2014, 55:174-179.
30. Carabini L.M., Navarre W.J., Ault M.L., Bebawy J.F., Gupta D.K. A comparison of hemoglobin measured by co-oximetry and central laboratory during major spine fusion surgery. Anesth. Analg. 2015, 120:60-65.
31. Carneiro D.M., Irvin G.L. New point-of-care intraoperative parathyroid hormone assay for intraoperative guidance in parathyroidectomy. World J. Surg. 2002, 26:1074-1077.
32. Carneiro D.M., Solorzano C.C., Nader M.C., Ramirez M., Irvin III G.L., Udelsman R., et al. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?. Surgery 2003, 134:973-981.
33. Carpenter C.R., Keim S.M., Worster A., Rosen P. Brain natriuretic peptide in the evaluation of emergency department dyspnea: is there a role?. J. Emerg. Med. 2012, 42:197-205.
34. Catlin D.H., Fitch K.D., Ljungqvist A. Medicine and science in the fight against doping in sport. J. Intern. Med. 2008, 264:99-114.
35. Cheng T.T., Yao J.L., Gao X., Sun W., Shi S., Yao T.M. A new fluorescence "switch on" assay for heparin detection by using a functional ruthenium polypyridyl complex. Analyst 2013, 138:3483-3489.
36. Chin C.D., Laksanasopin T., Cheung Y.K., Steinmiller D., Linder V., Parsa H., et al. Microfluidics-based diagnostics of infectious diseases in the developing world. Nat. Med. 2011, 17:1015-1019.
37. Christenson R.H., Azzazy H.M.E. Biochemical markers of the acute coronary syndromes. Clin. Chem. 1998, 44:1855-1864.
38. Clerico A., Zaninotto M., Prontera C., Giovannini S., Ndreu R., Franzini M., et al. State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study. Clin. Chim. Acta 2012, 414:112-119.
39. Clinical Laboratory Improvement Amendments of 1988 Public Law 100-578 1988, 2903-2915. (United States of America).
40. Cohen L.Y., Vernon M., Bergeron M.G. New molecular technologies against infectious diseases during space flight. Acta Astronaut. 2008, 63:769-775.
41. Cole D.E.C., Webb S., Chan P.C. Update on parathyroid hormone: new tests and new challenges for external quality assessment. Clin. Biochem. 2007, 40:585-590.
42. Collinson P.O., Garrison L., Christenson R.H. Cardiac biomarkers - a short biography. Clin. Biochem. 2015, 48:197-200.
43. Collopy K.T., Kivlehan S.M., Snyder S. What's the point of point-of-care testing? Understanding the potential of this evolving capability. EMS World 2014, 43:34-42.
44. Conrad D.N., Olson J.E., Hartwig H.M., Mack E., Chen H. A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay. J. Surg. Res. 2006, 133:38-41.
45. Cowie M.R., Jourdain P., Maisel A., Dahlstrom U., Follath F., Isnard R., et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur. Heart J. 2003, 24:1710-1718.
46. Coyle S., Morris D., Lau K.T., Diamond D., Taccini N., Costanzo D., et al. Textile sensors to measure sweat pH and sweat-rate during exercise. 2009 3rd International Conference on Pervasive Computing Technologies for Healthcare - Pervasive Health 2009 2009, PCTHealth.
47. Crucian B., Quiriarte H., Guess T., Ploutz-Snyder R., McMonigal K., Sams C. A miniaturized analyzer capable of white-blood-cell and differential analyses during spaceflight. Lab. Med. 2013, 44:304-312.
48. Culbertson C.T., Tugnawat Y., Meyer A.R., Roman G.T., Ramsey J.M., Gonda S.R. Microchip separations in reduced-gravity and hypergravity environments. Anal. Chem. 2005, 77:7933-7940.
49. Curto V.F., Fay C., Coyle S., Byrne R., O'Toole C., Barry C., et al. Real-time sweat pH monitoring based on a wearable chemical barcode micro-fluidic platform incorporating ionic liquids. Sensors Actuators B Chem. 2012, 171-172:1327-1334.
50. Dahlhausen B. Future veterinary diagnostics. J. Exot. Pet Med. 2010, 19:117-132.
51. D'Alessandra Y., Devanna P., Limana F., Straino S., Di Carlo A., Brambilla P.G., et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 2010, 31:2765-2773.
52. Danaher M., Jordan K. Identification of existing and emerging chemical residue contamination concerns in milk. Ir. J. Agric. Food Res. 2013, 52:173-183.
53. Daniels L.B., Maisel A.S. Cardiovascular biomarkers and sex: the case for women. Nat. Rev. Cardiol. 2015, 12:588-596.
54. Dascombe B.J., Reaburn P.R.J., Sirotic A.C., Coutts A.J. The reliability of the i-STAT clinical portable analyser. J. Sci. Med. Sport 2007, 10:135-140.
55. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991, 30:10363-10370.
56. Davis J. Medical issues for a mission to Mars. Aviat. Space Environ. Med. 1999, 70:162-168.
57. Davis F., Higson S.P.J. Label-free immunochemistry approach to detect and identify antibiotics in milk. Pediatr. Res. 2010, 67:476-480.
58. De Koninck A.S., De Decker K., Van Bocxlaer J., Meeus P., Van Hoovels L. Analytical performance evaluation of four cartridge-type blood gas analyzers. Clin. Chem. Lab. Med. 2012, 50:1083-1091.
59. Dittmer W.U., de Kievit P., Prins M.W.J., Vissers J.L.M., Mersch M.E.C., Martens M.F.W.C. Sensitive and rapid immunoassay for parathyroid hormone using magnetic particle labels and magnetic actuation. J. Immunol. Methods 2008, 338:40-46.
60. Dittmer W.U., Evers T.H., Hardeman W.M., Huijnen W., Kamps R., de Kievit P., et al. Rapid, high sensitivity, point-of-care test for cardiac troponin based on optomagnetic biosensor. Clin. Chim. Acta 2010, 411:868-873.
61. Dubeau-Laramée G., Rivière C., Jean I., Mermut O., Cohen L.Y. Microflow1, a sheathless fiber-optic flow cytometry biomedical platform: demonstration onboard the international space station. Cytometry A 2014, 85:322-331.
62. Dudek M.M., Lindahl T.L., Killard A.J. Development of a point of care lateral flow device for measuring human plasma fibrinogen. Anal. Chem. 2010, 82:2029-2035.
63. Erickson K.A., Wilding P. Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer. Clin. Chem. 1993, 39:283-287.
64. Esmon C.T. The regulation of natural anticoagulant pathways. Science 1987, 235:1348-1352.
65. Ewald M., Fechner P., Gauglitz G. A multi-analyte biosensor for the simultaneous label-free detection of pathogens and biomarkers in point-of-need animal testing. Anal. Bioanal. Chem. 2015, 407:4005-4013.
66. Faraoni D., Savan V., Levy J.H., Theusinger O.M. Goal-directed coagulation management in the perioperative period of cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2013, 27:1347-1354.
67. Fermann G.J., Suyama J. Point of care testing in the emergency department. J. Emerg. Med. 2002, 22:393-404.
68. Fischer S.P. Cost-effective preoperative evaluation and testing. Chest 1999, 115:96S-100S.
69. Fothergill N.J., Hunt M.T., Touquet R. Audit of patients with chest pain presenting to an accident and emergency department over a 6-month period. Arch. Emerg. Med. 1993, 10:155-160.
70. Fraser W.D., Colston K.W., JC Stevenson Bone and calcium metabolism. The Immunoassay Handbook 2013, 705-720.
71. Friess U., Stark M. Cardiac markers: a clear cause for point-of-care testing. Anal. Bioanal. Chem. 2009, 393:1453-1462.
72. Gallard E., Redonnet J.P., Bourcier J.E., Deshaies D., Largeteau N., Amalric J.M., et al. Diagnostic performance of cardiopulmonary ultrasound performed by the emergency physician in the management of acute dyspnea. Am. J. Emerg. Med. 2015, 33:352-358.
73. Gao P., D'Amour P. Evolution of the parathyroid hormone (PTH) assay - importance of circulating PTH immunoheterogeneity and of its regulation. Clin. Lab. 2005, 51:21-29.
74. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 2010, 56:254-261.
75. Giraud B., Frasca D., Debaene B., Mimoz O. Comparison of haemoglobin measurement methods in the operating theatre. Br. J. Anaesth. 2013, 111:946-954.
76. Goodacre S., Bradburn M., Fitzgerald P. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol. Assess. 2011, 15:iii-ixi.
77. Goodman W.G. The evolution of assays for parathyroid hormone. Semin. Dial. 2005, 18:296-301.
78. Gu X., Zhang G., Zhang D. A new ratiometric fluorescence detection of heparin based on the combination of the aggregation-induced fluorescence quenching and enhancement phenomena. Analyst 2012, 137:365-369.
79. Gu C.M., Lan t, HC Shi, Y Lu Portable detection of melamine in milk using a personal glucose meter based on an in vitro selected structure-switching aptamer. Anal. Chem. 2015, 87:7676-7682.
80. Guarda L.A. Rapid intraoperative parathyroid hormone testing with surgical pathology correlations: the "chemical frozen section". Am. J. Clin. Pathol. 2004, 122:704-712.
81. Gubala V., Harris L.F., Ricco A.J., Tan M.X., Williams D.E. Point of care diagnostics: status and future. Anal. Chem. 2012, 84:487-515.
82. Harris L.F., Castro-López V., Killard A.J. Coagulation monitoring devices: past, present, and future at the point of care. TrAC Trends Anal. Chem. 2013, 50:85-95.
83. Harrison C.R. Role of capillary electrophoresis in the fight against doping in sports. Anal. Chem. 2013, 85:6982-6987.
84. Herbstreit F., Winter E.M., Peters J., Hartmann M. Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests. Anaesthesia 2010, 65:44-49.
85. Hirsh J. Drug therapy: heparin. N. Engl. J. Med. 1991, 324:1565-1574.
86. Hirsh J., Dalen J.E., Anderson D.R., Poller L., Bussey H., Ansell J., et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998, 114:445S-469S.
87. Hirsh J., Fuster V., Ansell J., Halperin J.L. American Heart Association/American College of Cardiology foundation guide to warfarin therapy. Circulation 2003, 107:1692-1711.
88. Hogervorst E., Rosseel P., Van Der Bom J., Bentala M., Brand A., Van Der Meer N., et al. Tolerance of intraoperative hemoglobin decrease during cardiac surgery. Transfusion 2014, 54:2696-2704.
89. Hortin G.L., Carter A.B. Intraoperative parathyroid hormone testing: survey of testing program characteristics. Arch. Pathol. Lab. Med. 2002, 126:1045-1049.
90. humanresearchwiki.jsc.nasa.gov Exploration Medical Condition List Accessed 2015 September 27. Available from:. https://humanresearchwiki.jsc.nasa.gov/images/6/62/EMCL_RevC_2013.pdf.
91. humanresearchwiki.jsc.nasa.gov ExMC Gap Report 4.05 Accessed 2015 September 27, Available from:. https://humanresearchwiki.jsc.nasa.gov/index.php?title=4.0e5.
92. humanresearchwiki.jsc.nasa.gov Exploration Medical Capability (ExMC) Evidence Report Accessed 2015 September 27. Available from:. https://humanresearchwiki.jsc.nasa.gov/index.php?title=Exploration_Medical_Capability_(ExMC)_Evidence:Report.
93. Hwang R.S., Morris L.F., Ro K., Park S., Ituarte P.H.G., Hong J.C., et al. A selective, bayesian approach to intraoperative PTH monitoring. Ann. Surg. 2010, 251:1122-1126.
94. Irvin III G.L., Prudhomme D.L., Deriso G.T., Sfakianakis G., Chandarlapaty S.K.C. A new approach to parathyroidectomy. Ann. Surg. 1994, 219:574-581.
95. Ismail I., Wolff S., Gronfier A., Mutter D., Swantröm L.L. A cost evaluation methodology for surgical technologies. Surg. Endosc. 2015, 29:2423-2432.
96. Jaffe A.S., Babuin L., Apple F.S. Biomarkers in acute cardiac disease. The present and the future. J. Am. Coll. Cardiol. 2006, 48:1-11.
97. Jarrige V., Nieuwenhuis J.H., Van Son J.P.H.F., Martens M.F.W.C., Vissers J.L.M. A fast intraoperative PTH point-of-care assay on the Philips handheld magnotech system. Langenbeck's Arch. Surg. 2011, 396:337-343.
98. Jeter C.B., Hergenroeder G.W., Hylin M.J., Redell J.B., Moore A.N., Dash P.K. Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion. J. Neurotrauma 2013, 30:657-670.
99. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem. 2009, 55:1944-1949.
100. John A.S., Price C.P. Economic evidence and point-of-care testing. Clin. Biochem. Rev. 2013, 34:61-74.
101. Johnson L.R., Doherty G., Lairmore T., Moley J.F., Brunt L.M., Koenig J., et al. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin. Chem. 2001, 47:919-925.
102. Kanzaria H.K., Hoffman J.R., Probst M.A., Caloyeras J.P., Berry S.H., Brook R.H. Emergency physician perceptions of medically unnecessary advanced diagnostic imaging. Acad. Emerg. Med. 2015, 22:390-398.
103. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 2009, 361:868-877.
104. Khan A.A. Medical management of primary hyperparathyroidism. J. Clin. Densitom. 2013, 16:60-63.
105. Kim S.H., Lilot M., Murphy L.S.L., Sidhu K.S., Yu Z., Rinehart J., et al. Accuracy of continuous noninvasive hemoglobin monitoring: a systematic review and meta-analysis. Anesth. Analg. 2014, 119:332-346.
106. Kim T.K., Oh S.W., Hong S.C., Mok Y.J., Choi E.Y. Point-of-care fluorescence immunoassay for cardiac panel biomarkers. J. Clin. Lab. Anal. 2014, 28:419-427.
107. Koshy T.I., Buechler K.F. The Triage® system. The Immunoassay Handbook 2013, 541-544.
108. Kost G.J. Guidelines for point-of-care testing: improving patient outcomes. Am. J. Clin. Pathol. 1995, 104. (S111-S27).
109. Kost G.J. Preventing medical errors in point-of-care testing: security, validation, performance, safeguards, and connectivity. Arch. Pathol. Lab. Med. 2001, 125:1307-1315.
110. Kratz A., Ferraro M., Sluss P.M., Lewandrowski K.B. Laboratory reference values. N. Engl. J. Med. 2004, 351:1548-1563.
111. Larsson A., Greig-Pylypczuk R., Huisman A. The state of point-of-care testing: a European perspective. Ups. J. Med. Sci. 2014, 120:1-10.
112. La'ulu S.L., Roberts W.L. Performance characteristics of six intact parathyroid hormone assays. Am. J. Clin. Pathol. 2010, 134:930-938.
113. Lee W., Jung J., Hahn Y.K., Kim S.K., Lee Y., Lee J., et al. A centrifugally actuated point-of-care testing system for the surface acoustic wave immunosensing of cardiac troponin i. Analyst 2013, 138:2558-2566.
114. Lewandrowski K., Gregory K., MacMillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch. Pathol. Lab. Med. 2011, 135:1405-1414.
115. Li H., Han D., Pauletti G.M., Steckl A.J. Blood coagulation screening using a paper-based microfluidic lateral flow device. Lab Chip 2014, 14:4035-4041.
116. Liebes Y., Amir L., Marks R.S., Banai M. Immobilization strategies of Brucella particles on optical fibers for use in chemiluminescence immunosensors. Talanta 2009, 80:338-345.
117. Ludwig S.K.J., Tokarski C., Lang S.N., van Ginkel L.A., Zhu H.Y., Ozcan A., Nielen M.W.F. Calling biomarkers in milk using a protein microarray on your smartphone. PLoS ONE 2015, 10:0134360.
118. Macario A. What does one minute of operating room time cost?. J. Clin. Anesth. 2010, 22:233-236.
119. Mahajan V.S., Jarolim P. How to interpret elevated cardiac troponin levels. Circulation 2011, 124:2350-2354.
120. Maisel A.S., Choudhary R. Biomarkers in acute heart failure-state of the art. Nat. Rev. Cardiol. 2012, 9:478-490.
121. Mallett S.V., Cox D.J.A. Thrombelastography. Br. J. Anaesth. 1992, 69:307-313.
122. Markin A., Strogonova L., Balashov O., Polyakov V., Tigner T. The dynamics of blood biochemical parameters in cosmonauts during long-term space flights. Acta Astronaut. 1998, 42:247-253.
123. Martinez A., Phillips S., Nie Z., Cheng C.M., Carrilho E., Wiley B., et al. Programmable diagnostic devices made from paper and tape. Lab Chip 2010, 10:2499-2540.
124. Maule J., Wainwright N., Steele A., Monaco L., Morris H., Gunter D., et al. Rapid culture-independent microbial analysis aboard the International Space Station (ISS). Astrobiology 2009, 9:759-775.
125. Mayo D.D., Colletti J.E., Kuo D.C. Brain natriuretic peptide (BNP) testing in the emergency department. J. Emerg. Med. 2006, 31:201-210.
126. Mazzei F., Antiochia R., Botrè F., Favero G., Tortolini C. Affinity-based biosensors in sport medicine and doping control analysis. Bioanalysis 2014, 6:225-245.
127. McCrory P., Meeuwisse W., Johnston K., Dvorak J., Aubry M., Molloy M., et al. Consensus statement on concussion in sport - the 3rd International Conference on Concussion in Sport held in Zurich, November 2008. S. Afr. J. Sports Med. 2009, 21:36-46.
128. McGrath T.F., McClintock L., Dunn J.S., GM Husar, MJ Lochhead, Sarver R.W., et al. Development of a rapid multiplexed assay for the direct screening of anitmicrobial residues in raw milk. Anal. Bioanal. Chem. 2015, 407:4459-4472.
129. McPartlin D.A., O'Kennedy R.J. Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations. Expert. Rev. Mol. Diagn. 2014, 14:979-998.
130. Moore R.E. An historical perspective on the clinical diagnostic laboratory. Mol. Diagn. 2005, 3-10.
131. Morris H.C., Damon M., Maule J., Monaco L.A., Wainwright N. Rapid culture-independent microbial analysis aboard the International Space Station (ISS) stage two: quantifying three microbial biomarkers. Astrobiology 2012, 12:830-840.
132. Mougios V. Reference intervals for serum creatine kinase in athletes. Br. J. Sports Med. 2007, 41:674-678.
133. Nachtwey D. Radiological health risks for exploratory class missions in space. Acta Astronaut. 1991, 23:227-231.
134. Nelson E. Design principles for microfluidic biomedical diagnostics in space. Biomedical Engineering - From Theory to Applications 2011, 131-156. R. Fazel (Ed.).
135. Space Physiology and Medicine 1994, Lea and Febiger, Philadelphia, Pa. third ed. A. Nicogossian, C. Huntoon, S. Pool (Eds.).
136. North S.H., Shriver-Lake L.C., Taitt C.R., Ligler F.S. Rapid analytical methods for on-site triage for traumatic brain injury. Annu. Rev. Anal. Chem. 2012, 5:35-56.
137. ntrs.nasa.gov Portable diagnostics technology assessment for space missions Accessed 2015 September 27. Available from:. http://ntrs.nasa.gov/archive/nasa/casi.ntrs.nasa.gov/20100011008.pdf.
138. O'Connor T.P., Lawrence J., Andersen P., Leathers V., Workman E. Immunoassay applications in veterinary diagnostics. The Immunoassay Handbook 2013, 623-645.
139. O'Donoghue M., Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels?. Nat. Rev. Cardiol. 2010, 7:13-20.
140. Okuyama Y., Matsuo M., Matsuo H., Sakaguchi Y., Takai H., Horiguchi Y., et al. Introduction of point-of-care testing in Japanese outpatient clinics is associated with improvement in time in therapeutic range in anticoagulant-treated patients. Circ. J. 2014, 78:1342-1348.
141. Oncescu V., O'Dell D., Erickson D. Smartphone based health accessory for colorimetric detection of biomarkers in sweat and saliva. Lab Chip 2013, 13:3232-3237.
142. O'Reilly M. Considerations for evaluating the accuracy of hemoglobin monitoring. Anesthesiology 2012, 117:429-430.
143. Özcan H.M., Sezgintürk M.K. Detection of parathyroid hormone using an electrochemical impedance biosensor based on PAMAM dendrimers. Biotechnol. Prog. 2015, 31:815-822.
144. Panteghini M. Diagnostic application of CK-MB mass determination. Clin. Chim. Acta 1998, 272:23-31.
145. Papadea C., Foster J., Grant S., Ballard S.A., Cate Iv J.C., Southgate W.M., et al. Evaluation of the i-STAT Portable Clinical Analyzer for point-of-care blood testing in the intensive care units of a University Children's Hospital. Ann. Clin. Lab. Sci. 2002, 32:231-243.
146. Peacock W.F., Braunwald E., Abraham W., Albert N., Burnett J., Christenson R., et al. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J. Am. Coll. Cardiol. 2010, 56:343-351.
147. Peña J.A., Lewandrowski K.B., Lewandrowski E.L., Gregory K., Baron J.M., Van Cott E.M. Evaluation of the i-STAT point-of-care capillary whole blood prothrombin time and international normalized ratio: comparison to the Tcoag MDAII coagulation analyzer in the central laboratory. Clin. Chim. Acta 2012, 413:955-959.
148. Petricevic M., Kopjar T., Biocina B., Milicic D., Kolic K., Boban M., et al. The predictive value of platelet function point-of-care tests for postoperative blood loss and transfusion in routine cardiac surgery: a systematic review. Thorac. Cardiovasc. Surg. 2015, 63:2-20.
149. Pirozzi C., Numis F.G., Pagano A., Melillo P., Copetti R., Schiraldi F. Immediate versus delayed integrated point-of-care-ultrasonography to manage acute dyspnea in the emergency department. Crit. Ultrasound J. 2014, 6:5.
150. Pitts S.R., Carrier E.R., Rich E.C., Kellermann A.L. Where Americans get acute care: increasingly, it's not at their doctor's office. Health Aff. 2010, 29:1620-1629.
151. Poesen K., De Prins M., Van Den Berghe G., Van Eldere J., Vanstapel F. Performance of cassette-based blood gas analyzers to monitor blood glucose and lactate levels in a surgical intensive care setting. Clin. Chem. Lab. Med. 2013, 51:1417-1427.
152. Potts J.T. Parathyroid hormone: past and present. J. Endocrinol. 2005, 187:311-325.
153. Qureshi A., Gurbuz Y., Niazi J.H. Biosensors for cardiac biomarkers detection: a review. Sensors Actuators B Chem. 2012, 171-172:62-76.
154. Rebel A., Rice M.A., Fahy B.G. The accuracy of point-of-care glucose measurements. J. Diabetes Sci. Technol. 2012, 6:396-411.
155. Regiart M., Fernández-Baldo M.A., Spotorno V.G., Bertolino F.A., Raba J. Ultra sensitive microfluidic immunosensor for determination of clenbuterol in bovine hair samples using electrodeposited gold nanoparticles and magnetic micro particles as bio-affinity platform. Biosens. Bioelectron. 2013, 41:211-217.
156. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 2009, 361:858-867.
157. Reichlin T., Schindler C., Drexler B., Twerenbold R., Reiter M., Zellweger C., et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch. Intern. Med. 2012, 172:1211-1218.
158. Rhee A.J., Kahn R.A. Laboratory point-of-care monitoring in the operating room. Curr. Opin. Anaesthesiol. 2010, 23:741-748.
159. Rice M.J., Pitkin A.D., Coursin D.B. Glucose measurement in the operating room: more complicated than it seems. Anesth. Analg. 2010, 110:1056-1065.
160. Richards M.L., Thompson G.B., Farley D.R., Grant C.S. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch. Surg. 2011, 146:280-285.
161. Rooney K.D., Schilling U.M. Point-of-care testing in the overcrowded emergency department - can it make a difference?. Crit. Care 2014, 18.
162. Sabatine M.S., Morrow D.A., de Lemos J.A., Gibson C.M., Murphy S.A., Rifai N., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002, 105:1760-1763.
163. Saenger A.K., Jaffe A.S. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation 2008, 118:2200-2206.
164. Salem M., Chernow B., Burke R., Stacey J., Slogoff M., Sood S. Bedside diagnostic blood testing: its accuracy, rapidity, and utility in blood conservation. J. Am. Med. Assoc. 1991, 266:382-389.
165. Samara E.M., Ayadi M., Aljumaah R.S. Feasibility of utilising an infrared-thermographic technique for early detection of subclinical mastitis in dairy camels (Camelus dromedarius). J. Dairy Res. 2014, 81:38-45.
166. Samsonova J.V., Cannavan A., CT Elliott A critical review of screening methods for the detection of chloramphenicol, thiamphenicol and florfenicol residues in foodstuffs 2012, 42:50-78.
167. Saner F.H. Rotational thrombelastometry: a step forward to safer patient care?. Crit. Care 2014, 18.
168. Santini S.A., Carrozza C., Vulpio C., Capoluongo E., Luciani G., Lulli P., et al. Assessment of parathyroid function in clinical practice: which parathyroid hormone assay is better?. Clin. Chem. 2004, 50:1247-1250.
169. Santos P.M., Pereira E.R., Rodriguez-Saona L.E. Application of hand-held and portable infrared spectrometers in bovine milk analysis. J. Agric. Food Chem. 2013, 61:1205-1211.
170. Sanvicens N., Mannelli I., Salvador J.P., Valera E., Marco M.P. Biosensors for pharmaceuticals based on novel technology. TrAC Trends Anal. Chem. 2011, 30:541-553.
171. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 2011, 123:1367-1376.
172. Sayikli Şimşek Ç., Nur Sonuç Karabota M., MK Sezgintürk A new immobilization procedure for development of an electrochemical immunosensor for parathyroid hormone detection based on gold electrodes modified with 6-mercaptohexanol and silane. Talanta 2015, 144:210-218.
173. Schlebusch H., Paffenholz I., Zerback R., Leinberger R. Analytical performance of a portable critical care blood gas analyzer. Clin. Chim. Acta 2001, 307:107-112.
174. Schuur J.D., Carney D.P., Lyn E.T., Raja A.S., Michael J.A., Ross N.G., et al. A top-five list for emergency medicine a pilot project to improve the value of emergency care. JAMA Inter. Med. 2014, 174:509-515.
175. Semkova J.V., TsP D., YuN M., Koleva R.T., Baynov P.T., Tomov B.T., et al. Proposal for a new radiation dose control system for future manned space flights. Acta Astronaut. 1995, 36:629-638.
176. Shan R., Szmydynger-Chodobska J., Warren O.U., Mohammad F., Zink B.J., Chodobski A. A new panel of blood biomarkers for the diagnosis of mild traumatic brain injury/concussion in adults. J. Neurotrauma 2015, 9.
177. Shi W., Zheng S., Kasdan H.L., Fridge A., Tai Y.C. Leukocyte count and two-part differential in whole blood based on a portable microflow cytometer. TRANSDUCERS 2009 - 15th International Conference on Solid-State Sensors, Actuators and Microsystems 2009, 616-619.
178. Silverman R., Yalow R.S. Heterogeneity of parathyroid hormone. Clinical and physiologic implications. J. Clin. Investig. 1973, 52:1958-1971.
179. Skelton V.A., Wijayasinghe N., Sharafudeen S., Sange A., Parry N.S., Junghans C. Evaluation of point-of-care haemoglobin measuring devices: a comparison of Radical-7™ pulse co-oximetry, HemoCue® and laboratory haemoglobin measurements in obstetric patients. Anaesthesia 2013, 68:40-45.
180. Skugor M., Gupta M., Navaneethan S.D. Evolution and current state of assays for measuring parathyroid hormone. Biochem. Med. 2010, 20:221-228.
181. Smith S.M., Davis-Street J.E., Fontenot T.B., Lane H.W. Assessment of a portable clinical blood analyzer during space flight. Clin. Chem. 1997, 43:1056-1065.
182. Sokoll L.J., Wians F.H., Remaley A.T. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing. Clin. Chem. 2004, 50:1126-1135.
183. Stalberg P., Sidhu S., Sywak M., Robinson B., Wilkinson M., Delbridge L. Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it "value-add" to decision-making?. J. Am. Coll. Surg. 2006, 203:1-6.
184. Steinkamp J.A., Romero A., Van Dilla M.A. Multiparameter cell sorting: identification of human leukocytes by acridine orange fluorescence. Acta Cytol. 1973, 17:113-117.
185. Storrow A.B., Jenkins C.A., Self W.H., Alexander P.T., Barrett T.W., Han J.H., et al. The burden of acute heart failure on U.S. emergency departments. JACC Heart Fail. 2014, 2:269-277.
186. Straume T., Loftus D., Li J., Coleman M., Davis C., McMonigal K., et al. Biomarker-detection technologies for comprehensive medical diagnosis during deep-space missions. Recent Pat. Space Technol. 2013, 3:13-23.
187. Thölking G., Mesters R., Dittrich R., Pavenstädt H., Kümpers P., Reuter S. Assessment of hemostasis after plasma exchange using rotational thrombelastometry (ROTEM). PLoS ONE 2015, 10.
188. Thurman D.J., Branche C.M., Sniezek J.E. The epidemiology of sports-related traumatic brain injuries in the United States: recent developments. J. Head Trauma Rehabil. 1998, 13:1-8.
189. Thygesen K., Mair J., Katus H., Plebani M., Venge P., Collinson P., et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur. Heart J. 2010, 31:2197-2204.
190. Udelsman R., Donovan P., Shaw C. Cure predictability during parathyroidectomy. World J. Surg. 2014, 38:525-533.
191. Van Houdt R., Mijnendonckx K., Leys N. Microbial contamination monitoring and control during human space missions. Planet. Space Sci. 2012, 60:115-120.
192. Vashist S., Luppa P., Yeo L., Ozcan A., Luong J. Emerging technologies for next-generation point-of-care testing. Trends Biotechnol. 2015, 33:692-705.
193. Velasco-Garcia M.N., Mottram T. Biosensor technology addressing agricultural problems. Biosyst. Eng. 2003, 84:1-12.
194. Venturini J.M., Stake C.E., Cichon M.E. Prehospital point-of-care testing for troponin: are the results reliable?. Prehosp. Emerg. Care 2013, 17:88-91.
195. Vieira J.G.H., Kunii I., Nishida S. Evolution of PTH assays. Arq. Bras. Endocrinol. Metabol. 2006, 50:621-627.
196. Vieira J.G.H., Kunii I.S., Ohe M.N., Carvalho A.B. Heterogeneity of carboxyl-terminal parathyroid hormone circulating forms in patients with hyperparathyroidism due to end stage renal disease. Arq. Bras. Endocrinol. Metabol. 2009, 53:1074-1078.
197. Wians F.H., Balko J.A., Hsu R.M., Byrd W., Synder W.H. Intraoperative vs central laboratory PTH testing during parathyroidectomy surgery. Lab. Med. 2000, 31:616-621.
198. www.abaxis.com VetScan VS2 Accessed 2015 September 27. Available from:. http://www.abaxis.com/veterinary/products/vs2.html.
199. www.abaxis.com VetScan i-STAT 1 Handheld Analyzer Accessed 2015 September 27. Available from:. http://www.abaxis.com/veterinary/products/istat.html.
200. www.abaxis.com Abaxis Products Accessed 2015 September 27. Available from:. http://www.abaxis.com/veterinary/products/.
201. www.abaxis.com VetScan Avian Influenza Rapid Test Accessed 2015 September 27. Available from:. http://www.abaxis.com/veterinary/products/avian-influenza-rapid-test.html.
202. www.abaxis.com Abaxis Rapid Tests Accessed 2015 September 28. Available from:. http://www.abaxis.com/veterinary/products/rapid-tests.html.
203. www.abbottpointofcare.com i-STAT Handheld Accessed 2015 September 27. Available from:. https://www.abbottpointofcare.com/products-services/istat-handheld.
204. www.accessdata.fda.gov CLIA - Clinical Laboratory Improvement Amendments - searchable database Aeccessed 2015 September 27. Available frome:. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfclia/search.cfm.
205. www.alere.com Alere Triage System Tests Accessed 2015 September 27. Available from:. http://www.alere.com/au/en/product-details/alere-triage-system-tests.html.
206. www.biomerieux-industry.com Adiavet Accessed 2015 September 27. Available from:. http://www.biomerieux-industry.com/veterinary-diagnostics/adiavet-real-time-pcr-kits-for-animal-diseases-diagnostic.
207. www.coaguchek.com Coaguchek XS System Accessed 2016 January 27. Available from:. http://www.coaguchek.com/coaguchek_patient/en/home/products/xs-system.html.
208. www.fda.gov CLIA categorizations Accessed 2015 September 27. Available from:. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/IVDRegulatoryAssistance/ucm39329.htm.
209. www.fda.gov Recommendations: Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices Accessed 2015 September 27. Available from:. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm079632.htm.
210. www.hemocue.us HemoCue Hb 201+ System Accessed 2016 January 27. Available from:. http://www.hemocue.us/~/media/hemocue-images/hemocue_us-images/pdf/hemoglobin%E2%80%93lit1056%E2%80%93hb-201product-sheet.pdf?la=en-US.
211. www.idexx.com LaserCyte Dx Hematology Analyzer Accessed 2015 September 27. Available from:. https://www.idexx.com/small-animal-health/products-and-services/lasercyte-dx-analyzer.html.
212. www.idexx.com SNAP Pro Mobile Device Accessed 2015 September 27. Available from:. https://www.idexx.com/small-animal-health/products-and-services/snap-pro-mobile-device.html.
213. www.lewin.com The value of diagnostics, innovation, adoption and diffusion into health care 2005 Accessed 2015 September 27. Available from:. http://www.lewin.com/~/media/Lewin/Site_Sections/Publications/ValueofDiagnostics.pdf.
214. www.neogen.com Genomic solutions for swine Accessed 2015 September 27. Available from:. http://www.neogen.com/Genomics/Swine.html.
215. www.wada-ama.org World Anti-Doping Agency Accessed 2015 September 27. Available from:. https://www.wada-ama.org/.
216. Yager P., Domingo G., Gerdes J. Point-of-care diagnostics for global health. Annu. Rev. Biomed. Eng. 2008, 10:107-144.
217. Yang Z., Min Zhou D. Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction. Clin. Biochem. 2006, 39:771-780.
218. Yu N., Leese G.P., Smith D., Donnan P.T. The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM 2011, 104:513-521.
219. Yu L., Shi Z.Z., Fang C., Zhang Y.Y., Liu Y.S., Li C.M. A disposable lateral flow-through strip for smartphone-camera to quantitatively detect alkaline phosphatase activity in milk. Biosens. Bioelectron. 2015, 69:307-315.
220. Zhuang G.-S., Liu J., Jia C.-P., Jin Q.-H., Zhao J.-L., Wang H.-M. Microchip-based capillary electrophoresis for determination of lactate dehydrogenase isoenzymes. J. Sep. Sci. 2007, 30:1350-1356.